Article
Oncogenic Kit signalling on the Golgi is suppressed by blocking secretory trafficking with M-COPA in gastrointestinal stromal tumours.
Cancer letters - 28 Feb 2018
Obata Yuuki, Horikawa Keita, Shiina Isamu, Takahashi Tsuyoshi, Murata Takatsugu, Tasaki Yasutaka, Suzuki Kyohei, Yonekura Keita, Esumi Hiroyasu, Nishida Toshirou, Abe Ryo
Abstract excerpt
Most gastrointestinal stromal tumours (GISTs) are caused by constitutively active mutations in Kit tyrosine kinase. The drug imatinib, a specific Kit inhibitor, improves the prognosis of metastatic GIST patients, but these patients become resistant to the drug by acquiring secondary mutations in the Kit kinase domain. We recently reported that a Kit mutant causes oncogenic signals only on the Golgi apparatus in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
